C. Moreno, A. Aiello, R. Di Virgilio, V. Mazzotta, and A. Antinori, “Cost-effectiveness analysis of nirmatrelvir/ritonavir in adult patients at high risk of progressing to severe COVID-19”, Grhta, vol. 11, no. 1, pp. 168–176, Jul. 2025.